Fool.com Headlines: Meet the Tiny Biotech Challenging Amgen and General Electric

Fool.com Headlines Fool.com Headlines

Monitor all your apps! Deploy New Relic and get your Nerd Life t-shirt. Monitor any web or mobile app in less than 2 minutes. Don't let performance ruin your bottom line. From our sponsors

Meet the Tiny Biotech Challenging Amgen and General Electric Nov 4th 2013, 21:29, by Maxx Chatsko, The Motley Fool Repligen only has one product in manufacturing equipment, but it may be a better way to capitalize on the growing trend in biotech manufacturing than Amgen and General Electric.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions